Steward Partners Investment Advisory LLC Raises Position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY)
Steward Partners Investment Advisory LLC grew its position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 47.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,050 shares of the company’s stock after acquiring an additional 12,200 shares during the […]
Steward Partners Investment Advisory LLC grew its position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 47.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,050 shares of the company’s stock after acquiring an additional 12,200 shares during the […]
